205 filings
Page 4 of 11
8-K
tw7rhep5bo m1
3 Jun 21
Entry into a Material Definitive Agreement
8:01am
8-K
ghyx7so 3745
11 May 21
Otonomy Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:10pm
8-K
gn6rewsbynb0 5yxf5o
9 Apr 21
Otonomy Announces Proposed Public Offering
12:00am
424B5
alqjrx5qqp7 3gurtx77
9 Apr 21
Prospectus supplement for primary offering
12:00am
424B5
uedtbt
7 Apr 21
Prospectus supplement for primary offering
4:01pm
8-K
xjovrtpw879 hq0g
22 Feb 21
Otonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménière’s Disease
7:16am
S-8
au3zs8xadp9mnhrztf
11 Feb 21
Registration of securities for employees
4:55pm
8-K
44vd6b0 jhe2pf119
11 Feb 21
Otonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
4:10pm
8-K
3ysnzrtl60s194nbopv2
4 Nov 20
Otonomy Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:10pm
8-K
bpuzjr
4 Aug 20
Otonomy Reports Second Quarter 2020 Financial Results and Provides Corporate Update
4:19pm
8-K
i8riqluvd 400r2x0fu
10 Jul 20
Otonomy Announces Pricing of $60.1 Million Public Offering
4:05pm
424B5
zgreitoz
10 Jul 20
Prospectus supplement for primary offering
4:02pm
8-K
p1fa519 4g
9 Jul 20
Otonomy Announces Proposed Public Offering
6:17am
424B5
i6m60bpaoy22sfx6
9 Jul 20
Prospectus supplement for primary offering
6:06am
8-K
pzjh115 pukretogs
6 Jul 20
Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of
4:14pm